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Abstract
Background: Congenital hypothyroidism (CH) is the most important cause of mental and physical retardation in
newborns. The prevalence of CH has been reported high in East Azerbaijan province of Iran. However, the risk
factors for CH are poorly understood. This study aimed to determine and compare risk factors for permanent and
transient CH in East Azerbaijan, Iran.
Methods: A case-control study was conducted in the Iranian national screening program for CH. This study
included 680 neonates: 340 neonates with confirmed CH and 340 matched healthy controls born at the same
period and from the same residential area as the cases. Multiple logistic regression analyses were used to estimate
the crude and adjusted odds ratios and 95% confidence intervals for the association between different risk factors
and transient and permanent CH.
Results: Out of the 680 participants, 364 (53.53%) were male. Family history of CH (OR = 5.09, 95% CI: 1.66–15.63),
neonatal jaundice (OR = 3.89, 95% CI: 2.36–6.43) and parental consanguineous relation (OR = 2.19, 95% CI: 1.51–3.17)
were associated with an increased risk of permanent CH. Likewise, the use of Betadine in pregnancy (OR = 4.87,
95% CI: 1.45–16.28), family history of CH (OR = 5.98, 95% CI: 2.04–17.48), neonatal jaundice (OR = 2.81, 95% CI: 1.75–
4.52), parental consanguineous relation (OR = 3.86, 95% CI: 1.92–5.74), and gestational age at birth (OR = 3.2, 95% CI:
1.90–5.41) were identified as risk factors for transient CH.
Conclusion: Family history, neonatal jaundice, gestational age at birth, and Betadine usage in pregnancy are
associated with CH.
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Introduction
Congenital hypothyroidism (CH) in neonates stems from
impaired thyroid hormone synthesis, which can lead to
severe mental retardation with inadequate development
of the child’s brain, in the absence of timely identifica-
tion or treatment. Neonatal CH occurs in both transient
and permanent forms. The distribution of CH varies
from country to country, for example, 1 in 2070 births
in the United States [1] and 1 in 2421 live births in
China [2]. The average incidence of CH in Fars province,
Iran is 1 in 1000 live births [3], 1:748 in Isfahan province
[4], while the average incidence rate in East Azerbaijan
province of Iran is 1 in 550–600 live births [5]. However,
a countrywide review study revealed that the average
incidence rate of CH is 2 in 1000 live births in Iran [6].
Evidence suggests the risk factors affecting the inci-
dence of neonatal CH is different in various countries.
For example, low birth weight and family history in
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China [7, 8], congenital anomalies, gender, gestational
diabetes, gestational age greater than 40 weeks in Egypt
[9], and congenital anomalies and twin pregnancy in
Italy [10] have been identified as risk factors for neonatal
CH. Moreover, lowering the diagnostic cut-off levels in
different CH screening programs could have contributed
to an increased prevalence of detected CH. There are
different screening cut-off levels in different countries,
which can lead to difficulties in comparing the preva-
lence of CH [7, 11].
There may be risk factors specific to the province that
might have contributed to the high prevalence of this
disease. Most of the studies conducted in Iran are often
descriptive rather than analytical and are based on the
city level small-sized samples. Moreover, few studies
have focused on the differences between the transient
and permanent state of the disease. Therefore, this case-
control study aimed to identify and compare important
risk factors affecting the incidence of transient and per-
manent CH in East Azerbaijan province, Iran.
Method
Study design
This case-control study was conducted on neonates
from East Azerbaijan province who had participated in
the national CH screening program. In Iran, medical
universities are responsible authorities for the health sys-
tem in each province. CH screening program is a na-
tional program in Iran with national guidelines
according to the best available evidence and WHO rec-
ommendations. In the national screening program for
CH, all neonates are screened within 3–5 days of birth.
This program is currently running by first-line health
service providers in all cities and villages of the Iranian
population. Screening tests are performed on filter paper
specimens and then they are sent to referral labs in the
center of provinces. All these processes are done in
paper form and the statistics are sent from bottom to
top [6, 12].
In this study, all neonates, who were born in East
Azerbaijan province from the beginning of 2011 to the
end of 2013 and were diagnosed with permanent or
transient CH following heel prick screening and con-
firmatory tests, were included in the case group. Based
on the province’s health ministry, the total number of
neonates with CH was 405. Of those, 65 neonates were
excluded due to study criteria, ethical considerations,
and the unavailability of the address or telephone num-
ber of the patients who migrated, therefore 340 patients
whose information was available at the health depart-
ment of the province that was included in the study. Of
340 neonates, 204 neonates had transient CH and 136
neonates had permanent CH.
Case subjects
The neonates with thyroid stimulating hormone
(TSH) > 20 mU/L in neonatal CH screening on the
heel prick screening, and with TSH > 10 mU/L and
free thyroxine (T4) < 6.5 μg/dl in venous blood test,
who had received levothyroxine for more than 3
years (according to the national guidelines) after
confirmation from the focal point program (often
overseen by an endocrinologist who is responsible
for initiating and ending treatment to prevent error
and integrate appropriate case management), were
chosen as permanent CH subjects. However, neo-
nates with TSH > 20 mU/L in neonatal CH screening
on the heel prick screening, and with TSH > 10 mU/
L and T4 < 6.5 μg/dl in venous blood test, who had
received levothyroxine for less than 3 years (accord-
ing to the national guidelines) after confirmation by
the focal point specialist, were included as transient
CH subjects.
Control subjects
The infants, who had TSH < 5mU/L in the heel prick
screening or TSH between 5 and 19.9 mU/L in heel
prick screening that had reduced to less than 5 mU/L in
the re-examination of the heel prick test or less than 10
mU/L in venous blood test, were categorized as healthy
control group after matching time of birth and residence
with the cases.
Data collection
Data was collected from the Ministry of Health
checklists. Some potential risk factors, such as the use
of Betadine (vaginal) during pregnancy by the mother
and the presence of jaundice in the neonate, were not
available on this checklist. We collected this informa-
tion from the household records collected at homes
and health centers. Betadine usage was defined as the
vaginal usage during the pregnancy at least once.
Neonatal jaundice was defined as jaundice presenting
within 28 days after birth.
Parental consanguineous relationship was defined as
any degree of family relationship between the neonate’s
mother and father.
The data on healthy controls were collected from the
Health Integrated System (SIB) and household records
collected at homes and health centers. In case of data
unavailability, in-person interviews were conducted.
Statistical analysis
The Kolmogorov-Smirnov test was used to assess the
normality of data distribution. The t-test was used to
compare the quantitative variables of the control and
case groups, if the data were normally distributed.
The chi-square test was used to compare the
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qualitative variables of the case and control groups
and data were present as median and quartile 1 and
quartile 3. Non-parametric test (Mann-Whitney) was
used if the distribution of data was not normal. Each
variable in the single-variable analysis that had P <
0.2, was analyzed by multiple logistic regression, to
evaluate the most important risk factors for transient
and permanent CH controlling the effect of con-
founders, and estimate the adjusted odds ratio (OR).
The effects of independent variables on the three-
state response variable (permanent, transient, and
control) were evaluated using the multiple logistic re-
gression. SPSS software (version 22) was used to
analyze the data. For all tests, the error rate was con-
sidered to be 5%.
Results
Overall, this study included a total of 680 participants
including 340 neonates with CH in the case group,
which consisted of 136 neonates with permanent CH
and 204 neonates with transient CH, and 340 healthy
neonates. Of all participants, 364 (53.53%) were male.
The percentage of newborn boys in the transient CH
group was 53.4% (n = 109) and 54.4% (n = 74) in the per-
manent CH group. The percentage of newborn boys in
the control group was 53.2% (n = 181).
Risk factors associated with transient CH
Table 1 shows the associations between the potential
risk factors and the transient CH. According to univari-
ate analysis, parental consanguineous marriage (P =
0.001), Betadine usage in pregnancy (P = 0.003), history
of CH in first-degree relatives (P = 0.001), neonatal jaun-
dice (P = 0.001), and gestational age (P = 0.001) were as-
sociated with transient CH.
Risk factors associated with permanent CH
Parental consanguineous marriage was significantly
more frequent in the case group (22.1% versus 12.9% in
the control group; P = 0.001) (Table 2). More mothers in
the case group had used Betadine during pregnancy than
those in the control group (4% versus 1.2%, P = 0.039).
History of CH in first-degree relatives and neonatal
jaundice were observed more frequently in the case
group than in the control group (P = 0.001).
Table 3 shows the comparison of gestational age and
birth length among three groups of participants: perman-
ent CH, transient CH and controls. The median birth
length of neonates with both permanent and transient CH
was 49 cm as compared to 50 cm in healthy infants (P =
0.002). Additionally, the median gestational age at birth in
both permanent and transient CH group was 38 weeks as
compared to 39 weeks in the control group and it was a
significant difference (P = 0.003).
Multiple logistic regression analysis
Table 4 shows the results of multiple logistic regression
analysis to assess the effects of different potential risk
factors for permanent and transient CH.
The use of Betadine during pregnancy (OR= 4.87, 95% CI:
1.45–16.28), history of CH in the first-degree relatives (OR=
5.98, 95% CI: 2.04–17.48), neonatal jaundice (OR= 2.81, 95%
CI: 1.75–4.52), and parental consanguineous marriage (OR=
3.86, 95% CI: 1.92–5.74), were associated with an increased
risk of transient CH. Moreover, increased gestational age at
birth was also associated with transient CH (P = 0.001), how-
ever, we did not found a significant association between ges-
tational age and permanent CH (P = 247).
Table 1 Association between transient congenital
hypothyroidism (CH) and potential risk factors
Variable Control
N = 340
Transient CH
N = 204
OR (95% CI) P value*
Gestational age (week)
≤ 37 310 153 3.44 (2.1–5.62) 0.001
> 37 30 51 1
Birth length (cm)
≤ 50 100 53 1.18 (0.8–1.75) 0.223
> 50 240 151 1
Parental consanguineous marriage
No 296 (87.1) 161 (78.9) 1 1
Yes 44 (12.9) 43 (21.1) 2.17 (1.57–3) 0.001
Betadine usage
No 336 (98.2) 191 (93.6) 1 1
Yes 4 (1.2) 13 (6.4) 5.62 (1.8–17.5) 0.003
Gender
Male 181 (53.2) 109 (53.4) 1 1
Female 159 (46.8) 95 (46.6) (0.72–1.4) 0.97
History of CH in the first degree
No 335 (98.5) 188 (92.2) 1 1
Yes 5 (1.5) 16 (7.8) 5.6 (2.02–15.5) 0.001
Neonatal jaundice
No 299 (87.9) 141 (69.1) 1 1
Yes 41 (12.1) 63 (30.9) 3.53 (2.26–5.51) 0.001
Birth weight (gr)
< 2500 19 (5.6) 23 (11.3) 1 1
4000–2500 308 (90.6) 174 (85.3) 0.39 (0.22–0.69) 0.01
> 2500 13 (3.8) 7 (3.4) 0.39 (0.15–1.3) 0.058
Mother’s age (year)
< 20 43 (12.6) 22 (10.8) 1 1
20–30 97 (28.5) 77 (37.7) 1.6 (0.89–2.94) 0.1
30–40 127 (37.4) 78 (38.2) 1.2 (0.36–1.42) 0.54
> 40 73 (21.5) 27 (13.2) 0.74 (0.78–1.45) 0.34
* Χ2 test was used in the all tests
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Regarding the permanent CH, history of CH in the
first-degree relatives (OR = 5.09, 95% CI: 1.66–15.63),
neonatal jaundice (OR = 3.89, 95% CI: 2.36–6.43), and
parental consanguineous marriage (OR = 2.19, 95% CI:
1.51–3.17) were associated with an increased risk of per-
manent CH (Table 4).
Discussion
This case-control study was performed to identify the
risk factors for CH as a multifactorial disease in East
Azerbaijan province. In this study, the incidence rate of
CH from the beginning of 2011 to the end of 2013 was
1 in 545 live births. In comparison, similar studies
around the world have reported an incidence of 1 in
2020 live births in Egypt [9], 1 in 2700 live births in Italy
[10], and 1 in 3447 live births in Australia [13]. There-
fore, it seems that the incidence rate of CH in East
Azerbaijan Province is higher than in other countries. In
Iran, a systematic review and meta-analysis study across
Table 2 The relationship between permanent congenital
hypothyroidism (CH) and potential risk factors
Variables Control
N = 340
Permanent CH
N = 136
OR (95% CI) P value*
Parental consanguineous marriage
No 296 (87.1) 106 (77.9) 1 1
Yes 44 (12.9) 30 (22.1) 2.31 (1.6–3.3) 0.001
Betadine usage
No 336 (98.8) 130 (95.5) 1 1
Yes 4 (1.2) 6 (4.4) 3.8 (1.07–13.8) 0.039
Sex
Boy 181 (53.2) 74 (54.4) 1 1
Girl 159 (46.8) 62 (56.6) 0.95 (0.64–1.42) 0.81
History of CH in the first degree family
No 335 (98.5) 121 (89) 1 1
Yes 5 (1.5) 15 (11) 8.25 (2.93–23.2) 0.001
Neonatal jaundice
No 299 (87.9) 84 (61.8) 1 1
Yes 41 (12.1) 52 (38.2) 4.5 (2.8–7.26) 0.001
Birth weight (gr)
< 2500 19 (5.6) 21 (15.4) 1 1
4000–2500 308 (90.6) 110 (80.9) 0.29 (0.14–0.56) 0.01
> 2500 13 (93.8) 5 (3.7) 0.31 (0.09–1.04) 0.059
Mother’s age (year)
< 20 43 (12.6) 24 (17.6) 1 1
20–30 97 (28.5) 48 (35.3) 1.6 (0.89–3.5) 0.1
30–40 127 (37.4) 41 (30.1) 1 (0.89–2.94) 0.11
> 40 73 (21.5) 23 (16.9) 0.31 (0.57–1.8) 0.93
*Chi-square test was used in the all tests
Table 3 Comparison of gestational age and birth length among controls, permanent and transient hypothyroidism
Variable Permanent CH Transient CH Control P
valuea
One
way
ANOVA
Median (Q25, Q75) Median (Q25, Q75) Median (Q25, Q75)
Birth length (cm) 49 (47–50) 49 (48–51) 50 (48–51) 0.002
Gestational age (week) 38 (38–40) 38 (37.2–39) 39 (38–40) 0.003
Q Quartile
aP-value indicates a significant mean difference among study groups
Table 4 The results of multiple logistic regression estimation of
effects of risk factors for transient congenital hypothyroidism
(CH) and permanent congenital hypothyroidism (CH)
VARIBLE Comparison of permanent
CH and controls (Adjusted
OR, 95% CIs)
Comparison of transient
CH and controls (Adjusted
OR, 95% CIs)
Parental consanguineous marriage
No 1 1
Yes 2.19 (1.51–3.17) 3.86 (1.92–5.74)
P value 0.001 0.001
Betadine usage in pregnancy
No 1 1
Yes 2.9 (0.93–11.4) 4.87 (1.45–16.28)
P value 0.135 0.01
History of CH in the first degree
No 1 1
Yes 5.09 (1.66–15.63) 5.98 (2.04–17.48)
P value 0.004 0.001
Neonatal jaundice
No 1 1
Yes 3.89 (2.36–6.43) 2.81 (1.75–4.52)
P value 0.001 0.001
Birth length
No 1 1
Yes 1.2 (0.73–1.97) 0.99 (0.65–1.53)
P value 0.465 0.685
Gestational age
No 1 1
Yes 1.47 (0.76–2.84) 3.20 (1.90–5.41)
P value 0.247 0.001
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all provinces revealed that the incidence rate of CH is 2
per1000 (ranged 1 to 3 in 1000) live births [6].
It is possible that high rates of consanguineous mar-
riage with an associated risk of hereditary thyroid hor-
mone deficiency and ethnicity are important factors in
increasing the incidence of CH in this province [14, 15].
The cut-off levels used in different screening programs
may also influence the incidence rate [16, 17]. For ex-
ample, the incidence of permanent CH in Greece [18]
was reported at 1:1758 and 1:2441 with TSH cut-off
levels of 10 and 20mU/L, respectively.
Throughout Iran, a cut-off level of TSH = 10mU/L is
used for screening [19]. Therefore, it seems that the
higher incidence of CH in East Azerbaijan province is at-
tributed to other genetic and environmental factors. In
this study, we found that almost 60% neonates with CH
had transient CH. These results suggest neonates with
CH should be followed up for a longer period to rule
out transient CH. However, most studies have only in-
cluded permanent CH patients [10, 20].
This study showed that history of CH in first-degree
relatives, consanguineous marriage, neonatal jaundice,
and birth height is associated with an increased risk of
CH. Moreover, in transient CH, in addition to the
above-mentioned risk factors, the use of Betadine in the
pregnancy and the gestational age are also associated
with an increased CH risk.
One of the most important risk factors identified in
this study and other national studies [6, 21] is the history
of CH in first-degree relatives and consanguineous mar-
riage. The frequency of history of CH in relatives was
11.5% in the case group and 1.5% in the control group.
This risk factor had the highest OR for both transient
and permanent CH, which is in line with the other stud-
ies from Iran [15, 22] as well as other countries [10].
Previous studies have shown that the risk of CH is
higher in Asian families than in other races [1], which
may be related to a higher prevalence of consanguineous
marriage. These results support the evidence for the
strong effect of the genetic factors in the pathogenesis of
transient and permanent CH. The genetic disorders
causing hypothyroidism, such as dyshormonogenesis,
show an autosomal recessive transmissions pattern [23].
Therefore, a history of thyroid disease in other family
members can be one of the main risk factors for CH,
and it is important to pay attention to family history in
pregnant mothers.
In the present study, 30.9% of the neonates with transient
CH and 38.2% of the neonates with permanent CH (as
compared to 11.3% healthy controls) suffered from neo-
natal jaundice. Other similar studies have also reported a
similar association between neonatal jaundice and CH [24].
This study, consistent with the findings of a previous
study [25], showed a significant association between the
birth length and the incidence of transient and perman-
ent CH. The incidence of permanent and transient CH
was higher amongst neonates with short height as com-
pared to neonates with normal height. Khammarnia and
colleagues also showed similar results with a two-fold in-
creased risk of CH among children with short height
than those with normal height [26].
In the present study, 53.5% of neonates with transi-
ent CH were boys and 46.5% girls, with male to fe-
male ratio of 1.14. In permanent CH, male to female
was 1.19 (54.5% boys and 45.5% girls). In our study,
there was no significant difference between male and
female sex among neonates with CH. Zainalzadeh
et al. also found no gender difference in the incidence
of CH in a study from East Azerbaijan province [27].
In most case-control studies, the sex factor has been
included as a matched variable [28]. However, other
studies indicate the role of the female gender as a
risk factor for CH [29, 30].
In this study, there was no relationship between ma-
ternal age and transient or permanent CH, similar to
previous studies showing a lack of relationship between
mother’s age and CH [14]. In contrast, Khammarnia and
colleagues [26] showed that infants born to young
mothers were at an increased risk of CH, Harris et al.
found that infants born to mothers aged 40 years or
older had an increased risk of CH [1].
This study showed no significant association between
birth weight and transient or permanent CH, as shown
by Khammarnia et al. previously [26].
In our study, Betadine usage in the pregnancy was a risk
factor for transient CH. Other studies from Iran have shown
similar results [14]. Studies have shown that iodine (present
in Betadine) has an inhibitory effect on thyroid hormone se-
cretion [31]. The use of iodine-containing substances during
pregnancy can be absorbed into the mother’s blood and se-
creted in breast milk. Therefore, newborns are more ex-
posed to iodine through the breast milk [32]. Use of
iodine-containing substances, such as vaginal Beta-
dine, due to rapid absorption through the skin and
mucosa, and immediately crossing through the pla-
centa, can cause an increase in iodine level in
mothers and, consequently, in newborns [32].
This study also showed an association between gesta-
tional age at birth and CH. Previous studies have exam-
ined the relationship between CH and gestational age at
birth. Medda et al in a study from Italy showed that only
a gestational age at birth above 41 weeks to be signifi-
cantly associated with CH [33]. In the study by Abedi
et al [34], gestational age at birth, after controlling the
effects of other variables in multiple regerssion analysis,
was not significantly associated with permanent CH;
however, gestational age at birth was found to be a risk
factor for transient CH.
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Limitations
A limitation of this study is selection bias due to the in-
formation for patients from Sarab city in the province
was not accessible and therefore had to be excluded. An-
other concern is random error; however, because of our
large sample size as compared to the previous studies, it
is likely that this bias is small. Additionally, in order to
reduce the effect of potential confounders, the case and
control groups were matched for their birth season and
birthplace.
Conclusions
The incidence rate of CH in East Azerbaijan province is
1 in 545 live births. History of CH in first degree rela-
tives, parental consanguineous marriage, neonatal jaun-
dice, and birth length are associated with an increased
risk of CH. Moreover, in transient CH, in addition to
the above risk factors, Betadine use by mothers and ges-
tational age at birth also increased the disease risk.
Abbreviation
CH: Congenital hypothyroidism
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